Height protein could be cancer and diabetes treatment target

May 16, 2014 by Bronwyn Adams, University of Queensland
Height protein could be cancer and diabetes treatment target
Dr Andrew Brooks and Professor Mike Waters

University of Queensland scientists have discovered that a protein that regulates how tall you grow could be used in treating diseases including cancer and diabetes.

Growth hormone, acting through its receptor, determines whether you are struggling to reach high shelves or bumping your head on doorways.

Researchers from UQ's Institute for Molecular Bioscience, led by Professor Mike Waters, have now found it is also an untapped target for drugs.

"People without don't die from cancer or diabetes, making it an ideal drug target," Professor Waters said.

"But we didn't know enough about how it functioned to be able to design cancer or that would bind to the receptor and turn it either on or off as appropriate.

"We've now figured out how growth hormone turns on its receptor at the molecular level, and so have a clear idea of which part of the molecule to target to design drugs to combat these diseases."

This is the culmination of 45 years of work studying growth hormone for Professor Waters, who originally cloned the receptor with Genentech, one of the world's leading biotechnology companies.

The discovery was published overnight in Science.

Dr Andrew Brooks, who led the study with Professor Waters, said the discovery had implications beyond cancer and diabetes.

"Growth is one of a group of proteins known as cytokine receptors, which are important targets for therapeutics for a range of disorders, including , blood disorders, osteoporosis and obesity," Dr Brooks said.

"Our understanding of how receptor functions should give us insights into how the other cytokine receptors work, which in turn will inform the design of therapeutics to target these cytokine receptors and to treat many diseases."

Explore further: New target for prostate cancer resistant to anti-hormone therapies

More information: Mechanism of Activation of Protein Kinase JAK2 by the Growth Hormone Receptor, Science, 2014.

Related Stories

New target for prostate cancer resistant to anti-hormone therapies

April 23, 2014
Prostate cancer becomes deadly when anti-hormone treatments stop working. Now a new study suggests a way to block the hormones at their entrance.

Target for obesity drugs comes into focus

October 11, 2012
(Medical Xpress)—Researchers at the University of Michigan have determined how the hormone leptin, an important regulator of metabolism and body weight, interacts with a key receptor in the brain.

Scientists discover new protein involved in lung cancer

February 27, 2014
Scientists from The University of Manchester – part of the Manchester Cancer Research Centre (MCRC) - have discovered a new protein that is involved in cancer and inflammation in lung tissue.

Novel technique switches triple-negative breast cancer cells to hormone-receptor positive cells

November 1, 2011
Within many hormone-receptor positive breast cancers lives a subpopulation of receptor-negative cells – knock down the hormone-receptor positive cells with anti-estrogen drugs and you may inadvertently promote tumor ...

Recommended for you

Foods combining fats and carbohydrates more rewarding than foods with just fats or carbs

June 14, 2018
Researchers show that the reward center of the brain values foods high in both fat and carbohydrates—i.e., many processed foods—more than foods containing only fat or only carbs. A study of 206 adults, to appear June ...

3-D imaging and computer modeling capture breast duct development

June 14, 2018
Working with hundreds of time-lapse videos of mouse tissue, a team of biologists joined up with civil engineers to create what is believed to be the first 3-D computer model to show precisely how the tiny tubes that funnel ...

Beating cancer at its own game with a Trojan horse telomerase

June 13, 2018
Telomerase is a reverse transcriptase that uses an RNA template to synthesize telomeres. These repeat sequences bind special proteins that fold the ends of chromosomes back onto themselves to create a stable cap. When this ...

Turning the tables on the cholera pathogen

June 13, 2018
Recent cholera outbreaks in regions that are ravaged by war, struck by natural disasters, or simply lack basic sanitation, such as Yemen or Haiti, are making the development of new and more effective interventions a near-term ...

Troves from a search for new biomarkers: blood-borne RNA

June 12, 2018
It's the critical first step in treating everything from strokes to cancer: a timely and accurate diagnosis. Today, doctors often rely on biomarkers, such as cardiac troponin, the protein that appears in the blood after a ...

High-tech treatment of open leg wounds no better than using regular dressings: study

June 12, 2018
A new study of open leg fractures suggests there is no difference to patient recovery whether high-tech negative pressure wound therapy devices are used, compared to standard dressings.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.